Search results
Results from the WOW.Com Content Network
The U.S. Army Biological Warfare Laboratories (USBWL) was a suite of research laboratories and pilot plant centers operating at Camp (later Fort) Detrick, Maryland, United States, beginning in 1943 under the control of the U.S. Army Chemical Corps Research and Development Command.
The U.S. biological defense research program exists today, conducting research to develop physical and medical countermeasures to protect service members and civilians from the threat of modern biological warfare. [3] Both the U.S. bio-weapons ban and the BWC restricted any work in the area of biological warfare to defensive in nature.
The Army Biological Laboratory tested each agent and the Army's Technical Escort Unit was responsible for the transport of all chemical, biological, radiological (nuclear) materials. Biological warfare can also specifically target plants to destroy crops or defoliate vegetation.
It was one of the first large-scale biological weapon trials that would be conducted under a "germ warfare testing program" that went on for 20 years, from 1949 to 1969.
The Mongols under Jani Beg besieged Caffa in 1343 and the Venetian territory of Tana, the cause of which was a brawl between Italians and Muslims in Tana. [7] The siege of Caffa lasted until February 1344, when it was lifted after an Italian relief force killed 15,000 Mongol troops and destroyed their siege machines.
De Mussis apparently recorded an early example of biological warfare in describing how the army of the Golden Horde hurled plague-infected cadavers over the city walls during the Siege of Caffa in 1346.
The "Dan Crozier Building", at USAMRIID, Fort Detrick, Maryland. The United States Army Medical Research Institute of Infectious Diseases (USAMRIID; / j uː ˈ s æ m r ɪ d /) is the United States Army's main institution and facility for defensive research into countermeasures against biological warfare.
Many of the vaccines that protect against biowarfare agents were first tested on humans in Operation Whitecoat. [4]According to USAMRIID, the Whitecoat operation contributed to vaccines approved by the U.S. Food and Drug Administration (FDA) for yellow fever and hepatitis, and investigational drugs for Q fever, Venezuelan equine encephalitis, Rift Valley fever, and tularemia.